RA Capital kicks off third VC fund as Peter Kolchinsky and Rajeev Shah bank $880M
RA Capital Management, one of the premier healthcare investment managers, is back with another fund to shepherd the next wave of life sciences innovations.
RA closed its third “Nexus” fund at $880 million, the firm announced Wednesday morning, as a means to supplement its investments in private companies. Like the previous two Nexus funds, the goal of Nexus 3 will be to work in tandem with RA’s evergreen fund to invest in therapeutics, diagnostics and other areas in life sciences.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.